Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4756522
Max Phase: Preclinical
Molecular Formula: C31H30F3NO5S
Molecular Weight: 585.64
Molecule Type: Unknown
Associated Items:
ID: ALA4756522
Max Phase: Preclinical
Molecular Formula: C31H30F3NO5S
Molecular Weight: 585.64
Molecule Type: Unknown
Associated Items:
Canonical SMILES: N[C@@H](CCC(=O)C[C@@H](CSC1(c2ccc(C(F)(F)F)cc2)c2ccccc2CCc2ccccc21)C(=O)O)C(=O)O
Standard InChI: InChI=1S/C31H30F3NO5S/c32-31(33,34)23-13-11-22(12-14-23)30(41-18-21(28(37)38)17-24(36)15-16-27(35)29(39)40)25-7-3-1-5-19(25)9-10-20-6-2-4-8-26(20)30/h1-8,11-14,21,27H,9-10,15-18,35H2,(H,37,38)(H,39,40)/t21-,27-/m0/s1
Standard InChI Key: SBYDSIBMTYAWBB-IDISGSTGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 585.64 | Molecular Weight (Monoisotopic): 585.1797 | AlogP: 5.68 | #Rotatable Bonds: 11 |
Polar Surface Area: 117.69 | Molecular Species: ZWITTERION | HBA: 5 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 1.82 | CX Basic pKa: 9.11 | CX LogP: 4.10 | CX LogD: 1.16 |
Aromatic Rings: 3 | Heavy Atoms: 41 | QED Weighted: 0.27 | Np Likeness Score: 0.23 |
1. Fukai R,Ogo N,Ichida T,Yamane M,Sawada JI,Miyoshi N,Murakami H,Asai A. (2021) Design, synthesis, and evaluation of a novel prodrug, a S-trityl--cysteine derivative targeting kinesin spindle protein., 215 [PMID:33640763] [10.1016/j.ejmech.2021.113288] |
Source(1):